ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 141 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 2.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $2,172,000 | +70.6% | 115,142 | +6.5% | 0.00% | +100.0% |
Q2 2019 | $1,273,000 | -13.5% | 108,154 | +0.3% | 0.00% | -33.3% |
Q1 2019 | $1,471,000 | +46.8% | 107,797 | +10.3% | 0.00% | +50.0% |
Q4 2018 | $1,002,000 | +9.2% | 97,762 | +77.3% | 0.00% | 0.0% |
Q3 2018 | $918,000 | -11.4% | 55,138 | -15.9% | 0.00% | 0.0% |
Q2 2018 | $1,036,000 | +29.5% | 65,588 | +4.1% | 0.00% | 0.0% |
Q1 2018 | $800,000 | +13.6% | 62,986 | +2.5% | 0.00% | +100.0% |
Q4 2017 | $704,000 | -19.5% | 61,446 | -13.9% | 0.00% | -50.0% |
Q3 2017 | $874,000 | +24.3% | 71,334 | +16.1% | 0.00% | 0.0% |
Q2 2017 | $703,000 | -40.3% | 61,416 | +8.5% | 0.00% | -33.3% |
Q1 2017 | $1,177,000 | +4.3% | 56,591 | +4.3% | 0.00% | 0.0% |
Q4 2016 | $1,128,000 | -33.4% | 54,254 | +5.0% | 0.00% | -40.0% |
Q3 2016 | $1,693,000 | +54.0% | 51,649 | +17.3% | 0.01% | +66.7% |
Q2 2016 | $1,099,000 | +86.3% | 44,025 | +82.9% | 0.00% | +50.0% |
Q1 2016 | $590,000 | -24.1% | 24,075 | +2.3% | 0.00% | -33.3% |
Q4 2015 | $777,000 | +15.5% | 23,525 | +14.5% | 0.00% | +50.0% |
Q3 2015 | $673,000 | -28.0% | 20,540 | +16.3% | 0.00% | -33.3% |
Q2 2015 | $935,000 | +251.5% | 17,655 | +91.4% | 0.00% | +200.0% |
Q1 2015 | $266,000 | +29.8% | 9,225 | +30.9% | 0.00% | 0.0% |
Q4 2014 | $205,000 | – | 7,050 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management III, LLC | 229,895 | $7,593,000 | 6.73% |
Foresite Capital Management II, LLC | 419,997 | $13,873,000 | 4.65% |
Cormorant Asset Management, LP | 757,475 | $25,019,000 | 2.99% |
NEXTHERA CAPITAL LP | 60,000 | $1,982,000 | 2.81% |
SENZAR ASSET MANAGEMENT, LLC | 557,170 | $18,403,325,000 | 2.05% |
Parametrica Management Ltd | 9,360 | $309,000 | 2.04% |
Partner Investment Management, L.P. | 36,756 | $1,214,000 | 1.99% |
PFM Health Sciences, LP | 1,890,030 | $62,428,000 | 1.90% |
PYRRHO CAPITAL MANAGEMENT, LP | 63,000 | $2,081,000 | 1.40% |
BB BIOTECH AG | 1,510,150 | $49,880,000 | 1.40% |